Skip to main content
Clinical Trials/NL-OMON36101
NL-OMON36101
Recruiting
Not Applicable

ong term follow up of the clinical and immunological responses following HPV 16 E6/E7 synthetic long peptides vaccination in women with HPV 16 positive vulvar intraepithelial neoplasia grade 3 - Long term follow up of HPV 16 E6/E7 SLP vaccine in VIN 3 lesions

eids Universitair Medisch Centrum0 sites19 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
VIN
Sponsor
eids Universitair Medisch Centrum
Enrollment
19
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients are eligible and will be included if they participated in the initial phase II study and provide informed consent for the current study.

Exclusion Criteria

  • There are no exclusion criteria for this follow up study.

Outcomes

Primary Outcomes

Not specified

Similar Trials